SDCBP and breast cancer: The overexpression of syntenin-1 has been reported in melanoma, lung, prostate, and breast cancer, which promotes tumorigenesis by regulating cell migration, invasion, proliferation, angiogenesis, apoptosis, immune response evasion, and metastasis.